Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Orelabrutinib (ICP-022) is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 83.00 | |
5 mg | In stock | $ 197.00 | |
10 mg | In stock | $ 332.00 | |
25 mg | In stock | $ 547.00 | |
50 mg | In stock | $ 758.00 | |
100 mg | In stock | $ 996.00 | |
500 mg | In stock | $ 1,990.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 228.00 |
Description | Orelabrutinib (ICP-022) is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK). |
Synonyms | ICP-022 |
Molecular Weight | 427.49 |
Formula | C26H25N3O3 |
CAS No. | 1655504-04-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (584.80 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Orelabrutinib 1655504-04-3 Angiogenesis Tyrosine Kinase/Adaptors BTK Malignancies Btk inhibit ICP022 antineoplastic Inhibitor chronic small Bruton tyrosine kinase ICP-022 ICP 022 lymphocytic leukemia cell inhibitor